Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]

Affiliations

• ¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
• ² Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
• ³ University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.
• ⁴ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
• ⁵ Leeds Cancer Centre and University of Leeds, Leeds, UK.
• ⁶ Department of Hematology, University Hospital Leuven, Leuven, Belgium.
• ⁷ Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
• ⁸ Oslo Myeloma Center, Oslo University Hospital, Oslo; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.
• ⁹ Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
• ¹⁰ University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
• ¹¹ Hôpital Claude Huriez, Lille University Hospital, Lille, France.
• ¹² Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany.
• ¹³ Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
• ¹⁴ Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
• ¹⁵ Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands.
• ¹⁶ Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.